Jumat, 26 Juni 2015

Synetiq - crowdsource neuromarketing mendapatkan seed fund 40.000 Euro

Every startup would like to know what’s in their customers’ brain. Synetiq has the tool for this. Synetiq provides businesses with valuable emotional insights about their marketing material directly from their customers’ brain.
Synetiq is building the world’s first crowdsourced neuromarketing platform where companies can test how people react to their ads, movies, branding on a global pool of testers in a fast and efficient way. They deliver clear results to help them improve their marketing and communication which will lead them to more sales. Meanwhile Synetiq creates a way to earn money from home for a wide range of people with minimal effort.
We have had an interview with David Ottlik, the co-founder and CEO of Synetiq after their successful accelerator program in Helsinki at Startup Sauna where they have received seed funding worth 40 000 EUR. Synetiq has been awarded at How To Web Bucharest as well, right after the Slush conference that also resulted in a lot of great opportunities for the team.
Many exciting things have happened in the past couple of weeks, including the Startup Sauna and the How To Web participation. Could you please tell us more about your experience?
Startup Sauna was an amazing experience. We have received a lot of support and valuable feedback related to shaping our vision, business development and pitching. The program was pretty busy, sometimes we ended up sleeping in the co-working space but it was definitely worth it. We have met great coaches, including investors, experts, lawyers, tax consultants and CEOs of big corporations. We were also pitching to the Prime Minister of South Korea and the CEO of Supercell. This was pretty cool!
During the 5 weeks long accelerator program, the product concept had been fine tuned, especially related to market and customer segments. The “Kick the shit out” session was extremely helpful every Friday while the participants outlined the 3 things that they were proud of,  the 3 most important barriers and 3 things that they going to do the week after. We were pitching hundreds of times for sure.
Startup Sauna has spared us months of learning time. The amount of knowledge, the network and the expertise was really valuable for us. We were lucky that we were at an early phase and this is the stage where this program could help the most. Slush was a huge event, with 6000 people, 1100 companies and 500 investors from all around the globe. With Synetiq we had a boost, that was valuable as we have had the chance to talk with hundreds of people that resulted in more than 20 leads and a pitch in the news on national TV.

Also find out more about Indonesia First Neuromarketing Agency - EMC SQUARE ( www.emc-square.com )

Neurospire mendapatkan dana segar dari Capital A Partner

CHARLESTON, SC: July 1, 2014 – Capital A Partners has participated in the Series A investment in NeuroSpire, a Durham, NC-based neuroscience technology company. The company has been licensing its neuromarketing software platform to companies in North and South America, Europe, the Middle East and South Africa since its inception in 2010. Its new offering, NEURO+, applies neuroscience combined with gaming to treat children struggling with ADHD. Past clinical research shows neurofeedback to be as effective as pharmaceutical solutions at treating brain-centered conditions.

 NeuroSpire’s NEURO+ offering will be one of the first commercially available applications in neuroscience for clinical treatment of ADHD. The company’s application combines neurofeedback with popular gaming platforms to provide clinicians and parents an alternative to pharmaceutical treatments. Future applications of the technology include improving mental readiness in athletes and military personnel, as well as treating anxiety, depression and addiction. “Applying proven neuroscience technology through gaming to solve one of our society’s most challenging problems in education is core to our excitement about NeuroSpire,” stated David Mendez, General Partner at CAP A.

“Replacing pharmaceutical treatments with a more sustainable and equally effective solution in the treatment of these conditions is literally a game changer,” added Mendez. Jake Stauch, CEO and founder of NeuroSpire, is a former researcher at the Duke University Center for Cognitive Neuroscience. He founded the company in 2010, and was previously awarded grant funding through NC IDEA and the Duke Innovation & Entrepreneurship Initiative, and was awarded prizes from both the ACC Startup Madness and Duke Startup Challenge competitions.

About four years ago, Jake Stauch was in a neuroscience class at Duke, learning about an intriguing experiment. In it, subjects went through an fMRI while being shown photos of Godiva chocolates. A price accompanied the chocolates, and the subjects had to answer yes or no, would they buy this? Some of their neurons lit up like wildfire.

Chances are, if Stauch was strapped into a machine, his brain would've flickered at the idea, too. Stauch, a confirmed whiz who in high school got a perfect 2400 on his SAT while fighting bronchitis, was inspired. It was an innovative technique, reaching inside buyers' skulls to see what they thought before products even hit the shelves. So he started combing through something like 150 peer-reviewed neuroscience articles. A year later, he founded NeuroSpire, a Durham, North Carolina-based business that gives marketing companies everything they need to conduct their own brain scan-based marketing tests.

"Somebody with no training whatsoever could be set up in minutes to run a brain imaging research study," he says. The guesswork of advertising is turned into numbers that purport to help companies get a window into consumers' heads: to see if They'll buy it, or They won't. That might help explain why ad agencies such as McKinney--which counts Samsung and Sherwin-Williams among its clients--have signed up for NeuroSpire, despite that the scientific merits of such services remain murky.

  Also find out more about Indonesia First Neuromarketing Agency - EMC SQUARE ( www.emc-square.com )

7 Kelemahan Neuromarketing

I got quoted in a random neuromarketing article recently. In the flurry of people I have been chatting with about statistics and functional neuroimaging I often neglect to ask what organizations people are associate with. In this case it was Forbes magazine. http://www.forbes.com/forbes/2009/1116/marketing-hyundai-neurofocus-brain-waves-battle-for-the-brain.html In the online version of the article there was a user comment from a neuromarketing company CEO defending the honor of his business and the field in which they operate. He went so far as to compare the launch of neuromarketing with the initial steps of market research in the early 20th century. He further argued that neuromarketing would bring about the next revolution in understanding consumer behavior. I have to admit, my gut reaction on first reading this statement was one of mild disgust. This got me thinking about why neuromarketing hangs in a cloud of disdain among many scientists. Below are some of the ‘sins’ which I feel currently plague the field of neuromarketing. This is all just my opinion of course, but I do think that it raises some interesting points for discussion.

 1) The curtain of proprietary analysis methods limits our knowledge of how effective neuromarketing can be. Neuromarketing seems to be primarily driven by the private industry, not academia. This is not to say that research into consumer behavior has not occurred at the university level. There has been a lot of good neuroeconomics research in the last several years. Still, it is mostly companies in private industry that are driving the application of these findings to practical consumer behaviors. Because these companies are in competition with each other they are reluctant to give others the recipe to their secret analysis sauce. From the outside this means that the analysis pipeline of all neuromarketing companies is that of a black box, with data going in one end and the results-you-need coming out the other. My colleagues and I have the position that fMRI research utilizing incorrect statistics can generate a large number of false positives. That is, many of the results will be there simply because of noise. Because so much of the current neuromarketing data is hidden behind the veil of proprietary analysis methods it is impossible to judge how successful their methods actually are, and to what degree their findings are false positives.

 2) There is little peer-reviewed literature that is specific to neuromarketing. Neuromarketing is an emerging discipline that will, in time, give us new insight into human behavior. Unfortunately, little peer-reviewed research has currently been published in this area. Search for ‘neuromarketing‘ in the PubMed database of abstracts (www.pubmed.com) and you will find all of ten publications. This must change for neuromarketing to mature. Again, without peer-reviewed results on the effectiveness of neuromarketing experiments all we have to rely on are self-reports from the neuromarketing firms themselves. An issue similar to the file-drawer problem then exists. The file-drawer problem is when only positive results get published in journals while negative results sit unpublished in the file drawer. Neuromarketing companies will be likely to report positive results while negative results sit undistributed. Either way, the end result is a biased understanding.

 3) Most people’s introduction to neuromarketing is through press releases, not peer-reviewed studies. In 2006 there was an “instant-science” article released online by Marco Iacoboni et al. revealing their analysis of fMRI date obtain while subjects were watching Super Bowl advertisements. The much-discussed post, entitled “Who Really Won the Super Bowl?”, tried to determine the most effective commercial by judging which one activated regions involved in reward and empathy to the greatest degree. They determined that a commercial from Disney fared the best when evaluated by these measures. Many neuroscientists shook their heads and moved on. In 2009 the same group published an op-ed in the New York Times detailing the results of scanning 20 individuals while looking at pictures and videos of leading political candidates. They drew conclusions on candidate evaluations by examining activity in areas like the amygdala and anterior cingulate. For example, they concluded that amygdala activity indicated a state of anxiety and cingulate activity indicated cognitive conflict. These oversimplifications were so well publicized and widely distributed that a number of leading neuroscientists were compelled to publish a letter in the New York Times calling the Iacoboni results into question. Let’s put it this way, when many of the top minds in neuroimaging feel compelled to assemble a letter to the New York times regarding your non-peer-reviewed neuromarketing/neuropolitics results then the field has a problem. There are a handful of peer-reviewed neuromarketing papers that do deliver. One recent paper by Michael Schaefer was a very interesting investigation into the representation of brand associations. However, these type of studies are typically rare, and it remains that the signal-to-noise ratio of information in the press is very low. 

4) Neuromarketing methods are not immune to subjectivity and bias. One of the most highly touted aspects of neuromarketing methods is that they are free from subjectivity and bias on the part of the participant. For example, asking a subject what they thought of a particular brand introduces the muddying waters of conscious consideration. The person’s response will be colored by a complex web of tangential cognitive factors and contextual biases. The promise of neuromarketing is that you can bypass these confounding factors to get at the heart of the matter – the real representation of the brand. While this is true to a degree, an entirely new set of confounding factors is introduced during the analysis of neuromarketing data. While many neuromarketing measures are indeed more objective than verbal reports, I must disagree with the observation that they are unfiltered, true reports of the underlying representation. While the signals are not filtered by the consciousness of the research subject, a great deal of manipulation and filtering of the data is done by the researcher. This does introduce the potential for bias, simply by a different avenue. Small changes in processing pipelines can have a huge impact on the power of fMRI to detect relevant signals. Some excellent papers by Stephen Strother come to mind with regard to this point. With no knowledge of what is going on we have no idea how objective the analyses by these companies can be.

 5) The value per dollar of neuromarketing methods has yet to be determined. Neuromarketing studies are expensive. The Forbes article says that an average EEG or fMRI marketing study costs in the neighborhood of $50,000. Immediately this number can trigger a ‘more expensive = better’ response, especially if you have a large budget to support such studies. What rarely gets discussed is what kind of value you obtain in return for the huge amount of money that is spent. The key question in neuromarketing is what information can you get with EEG / fMRI / eye tracking / biometrics that you cannot obtain using other methods. If I can spend $1000 to do a traditional market study that gets me 85% of what a $50,000 fMRI study does then the return on my neuromarketing investment is not great. Thinking about it another way, how much less or more could I get across 50 traditional studies relative to the value of one neuromarketing study. Many companies are not limited by the extreme cost of neuromarketing studies, and a significant fraction of them are not afraid to take the risk to try something new. Perhaps part of the motivation is also the fear of being left behind – that a competitor will take the risk and gain a competitive advantage in consumer understanding. Whatever the motivation, there will always be a market for neuromarketing methods. Still, we must still acknowledge that the value of neuromarketing is an open question.

 6) People are rushing the field to make a quick buck, and not everyone is trustworthy. The emergence of neuromarketing represents a modern day gold rush in terms of buzz and promises. Brilliant researchers will be attracted to this opportunity and will significantly advance the field of neuromarketing. Morally questionable individuals will also be drawn to the opportunity, and will end up giving the field a black eye. Reputations will build up over time and trustworthy companies will emerge from the fray, but the current situation is more akin to the wild west than a civilized exchange.

 7) The true value of neuromarketing is obscured by the above-mentioned problems. I thought I would end on a high note. There is certainly significant value to using neuromarketing methods in consumer research. Why else would companies like Nielsen Holdings be investing in neuromarketing firms like NeuroFocus? One of the biggest problems is that the true value of these methods is obscured by those who treat it as a gimmick and have the loudest voice. The next ten years will represent a true shakedown of the neuromarketing industry. Companies that are able to provide real value to their customers will live on while those who simply seek to make pretty pictures will fall by the wayside. It will be a fascinating time to be an observer of the business and politics in this emerging field. Also find out more about Indonesia First Neuromarketing Agency - EMC SQUARE ( www.emc-square.com )

Customerclever.co.uk mendapatkan investasi pertamanya

Mercia Fund Management has committed to invest over $230,000 in UK-based facial recognition tech developer Customer Clever Ltd., according to report in Startups.co.uk. The investment will help support the tech firm’s development of an algorithm which determines gender, ethnicity, age and time of visit of retail customers.

Originally developed for homeland security applications such as border protection and terrorist detection, the algorithm is being adapted to help retail establishments better understand consumers and their habits. Rob Johnson, an Investment Director at Mercia Fund Management, commented: “We believe the biometrics sector will experience significant growth over the next decade, and Customer Clever is well placed to take first mover advantage with this innovative application within this growth industry and potentially establish a significant market share.”

In the near term, Biometrics Research Group Inc., a leading research vendor and publisher of BiometricUpdate.com, projects that the global biometrics market will grow to US$15 billion by 2015 from its 2012 estimated value of US$7 billion, and that facial recognition will be the second largest technological modality within the sector. Customer Clever Ltd. will reportedly use its new financing to “begin initial sales” and explore other technology adaptations to maximize its client benefits. Adam Whitchurch, Customer Clever CEO, said: “We are grateful to Mercia for this investment. Customer Clever offers an innovative solution to help businesses improve their marketing strategy, whilst providing a tailor-made, unique shopping experience for their customers.”

In other merger and acquisition news, Nielsen recently announced that it had completed its acquisition of Boston-based neuroscience firm Innerscope Research. Nielsen will merge Innerscope with NeuroFocus, another neuromarketing research firm it purchased in 2011. Advertisement Founded in 2006 by neuroscientist Dr. Carl Marci and MIT alumnus Brian Levine, Innerscope Research specializes in biometric measurement, combining neuroscience and biometrics with its own proprietary software to measure audience engagement.

As previously reported, Innerscope Research recently published a new biometric study that finds that traditional TV commercials are four times more engaging than video advertising on Facebook, according to a report by MediaPost. Using biometric monitoring, eye-tracking and traditional survey methods, Innerscope was able to measure the nonconscious and conscious responses of 390 consumers, ages 18 to 34, to the same video advertisements across Facebook, TV and digital pre-roll on PC, tablet and smartphone. According to Innerscope, the study was a “client commissioned” survey, although it did not disclose the name of the client. The research firm captured the biometric data using technology to record fluctuations in heart rate, skin conductance and breathing patterns.

We also reported in 2012 that Time, Inc conducted a media consumption study which utilized Innerscope’s monitoring systems. Subjects wore biometric belts as well as eye-tracking glasses to determine which form of media they were using and when visual attention was altered. “Putting the two units together creates a scale in consumer neuroscience that is fairly unmatched,” Nielsen Consumer Neuroscience President Joe Willke told Advertising Age. Dr. Marci will serve as the chief neuroscientist of the newly branded unit, which will now be known as Nielsen Consumer Neuroscience. Also find out more about Indonesia First Neuromarketing Agency - EMC SQUARE ( www.emc-square.com )

Disney Telah menerapkan Neuromarketing sejak dulu

From its theme parks to its cruise ships, not to mention its media ventures, Disney has been uncommonly good at crafting emotional appeals that work. One way they have done this is to employ a variety of neuromarketing (or consumer neuroscience, the term some prefer) technologies to gauge real consumer reactions. The lab isn’t quite so secret now. The operator of the lab, Media Science, is no longer under exclusive contract with Disney. Media Science now accepts work from a variety of clients. I toured the facility earlier this year, and was impressed by the variety of technology used by Media Science. They had biometrics, eye tracking, facial coding, and implicit testing, along with more conventional approaches like focus groups, surveys, and usability tests. The Austin lab was launched in 2008. Disney was clearly ahead of most big corporations in the practical application of neuromarketing techniques. Disney’s Brainy Success Disney has been remarkably successful over the years. I’d attribute that in part to their keen interest in how our brains work and the importance of emotion in consumer behavior. Their 1943 cartoon to the contrary, Disney understands that whether we’re deciding on a vacation destination or choosing a movie, it’s not usually “reason” in the driver seat – it’s emotion! Also find out more about Indonesia First Neuromarketing Agency - EMC SQUARE ( www.emc-square.com )

Nielsen akuisisi perusahaan neuromarketing innerscope

Nielsen recently completed its acquisition of Innerscope Research and has renamed its Nielsen Neuro area Nielsen Consumer Neuroscience to reflect the total offering. The combined entity is now the largest consumer neuroscience organization in the world. Boston-based Innerscope has been a leader in integrating multiple consumer neuroscience tools, combining biometrics, neurometrics and psychometrics to deliver unprecedented understanding of consumer behavior. By adding Innerscope’s best-in-class biometrics and facial-coding technologies, along with additional expertise in eye tracking and integrating self-reporting to its EEG and other technologies, Nielsen Consumer Neuroscience now offers one comprehensive suite of conscious and non-conscious research solutions on a global scale. The unique and unparalleled insights gained from these combined technologies will empower clients to make even more informed and strategic business decisions with greater confidence and greater return on investment. “Through this acquisition, we will deliver to clients unprecedented understanding of consumer behavior that helps brands build deeper connections and optimize product and communication performance,” said Joe Willke, president of Nielsen Consumer Neuroscience. “We are delighted to welcome Innerscope Research into the Nielsen family.” This acquisition continues to demonstrate Nielsen’s leadership and investment in innovative methodologies to fully understand consumer behavior. And with this acquisition, Nielsen Consumer Neuroscience now has the capability to extend its consumer neuroscience research methodologies beyond the laboratory environment, as Innerscope brings expertise with its Sensus™ kiosk platform and in-home and in-store testing capabilities with leading-edge wearable technologies. “Integrated consumer neuroscience is at the heart of Innerscope Research, so we’re thrilled to become part of a company that also has a deep focus on using multiple tools to measure non-conscious responses related to consumer behavior,” said Dr. Carl Marci, chief neuroscientist for Nielsen Consumer Neuroscience and co-founder and former chief science officer for Innerscope Research. “By integrating our complementary technologies and science, we believe that Nielsen immediately becomes the largest and most complete consumer neuroscience company in the world. We can deploy the right tools for our clients, delivering unprecedented consumer insight across the globe.” Also find out more about Indonesia First Neuromarketing Agency - EMC SQUARE ( www.emc-square.com )

Revolusi Neuromarketing Dunia

Reading consumers’ minds or even finding the “Buy Button” is the secret dream of most marketers. Modern neuroimaging techniques offer a window to the brain at work. Can they help to design powerful brands and optimal advertisements? Neuroimaging techniques have been applied to a broad range of contexts: clinically, to diagnose and treat patients; experimentally, to better understand the brain and its diseases. Their extension to market research is appealing. Emotional processes are known to play a major role in purchase decisions, even outweighing rational processes in some cases. Standard market research, i.e. qualitative and quantitative market studies, product tests, pre- and post-advertising tests, sample the conscious side of the brain, whereas neuromarketing aims to probe both its conscious and unconscious sides. The princeps paper was published in Neuron in 2004, by McClure and colleagues [2]. Using functional MRI, they studied the footprint in the brain of two popular soda brands: Coca-Cola and Pepsi. They noticed that although the subjects preferred Pepsi during blind trials, they preferred Coca-Cola during non-blind trials. This preference was associated with greater activations of a memory-related area, the hippocampus, in line with Coca-Cola’s powerful branding. MRI is the gold standard for brain imaging, but it is expensive (approx. $1,500 per subject) and cannot be applied for field studies. Other methods, less expensive and more portable, have also been applied for neuromarketing purposes. Electroencephalography (EEG), measuring the electrical activity of the brain through a cap of electrodes positioned on the head, is the most interesting one. Its ability to sample the brain activity at a high rate, its portability, and its low cost compared to MRI, make it the first choice for most neuromarketing companies. However, its measurements are limited to the surface of the brain, whereas the emotional brain is mainly made of deep structures. Each technique has known limitations, and none of them is a mind reader. Neuromarketing Companies offering neuromarketing services have flourished all around the world, sometimes based on solid scientific grounds, but other times on crappy assumptions. Several issues make the interpretation of neuromarketing experiments particularly tricky. The brain’s organization is complex. In the 19th century, phrenology was parceling the brain into functional units, dedicated to various functions, such as adhesiveness, cautiousness, hope, etc. This theory has since then been swept away. The problem is well illustrated by New York Times’ popular article “You Love your iPhone. Literally”, reporting a study by San Diego-based firm MindSign Neuromarketing. From the fact that being in love and hearing a ringing iPhone both activate the insular cortex of the brain, the author, a well-known neuromarketing opinion leader, inferred that the subjects were in love with their iPhone. This conclusion breaks the basic rules of logic. As Molly Crockett’s excellent TEDx talk “Beware Neuro-Bunk” describes, the insular cortex is also activated by a lot of other tasks and emotions, including anger, disgust, and pain, making such a conclusion unfounded. Should companies invest in neuromarketing studies? For small companies, I would say no. They have other priorities and the return on investment of a neuromarketing study is debatable. For large groups, especially in the FMCG industry, and for academics, I would say that neuromarketing is a market research technique worth considering. It won’t replace other market studies; it will be complimentary. Is it ethical to probe a person’s brain in order to optimize a marketing campaign? The question is debatable, as discussed in the editorial of prestigious Lancet medical journal “Neuromarketing: beyond branding”. Most companies using neuromarketing keep it confidential. However, as in all other brain processes, purchasing decisions, at the center of our economy, are worth being studied. In addition, neuromarketing is a measurement method, like any other market research technique. It’s not a stimulation technique. Similarly, a thermometer measures the body temperature. It does not influence it. The “Buy Button” does not exist in our brain! Also find out more about Indonesia First Neuromarketing Agency - EMC SQUARE ( www.emc-square.com )